Biopharmaceutical manufacturing of proteins requires an efficient cell line. Starting with several thousand clones, researchers use multiple selection rounds to ultimately chose one clone for the ...

As regulatory authorities accelerate the use of New Approach Methodologies (NAMs), the drug discovery landscape is changing dramatically. This webinar explores how NAMs, immunology-driven platforms, ...

In early-stage drug discovery, in vitro models are essential for generating clinically relevant data that expedite the progress of potential therapeutics into clinical trials. However, most ...